Parkinson's Disease (PD)NCT07641569
Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease
A study testing Single Task Exercise Training, Motor-Motor Dual Task Exercise Training and Cognitive-Motor Dual Task Exercise Training in people with Parkinson's Disease (PD), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are: Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in… Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Parkinson's Disease (PD)
- What is being tested?
- Single Task Exercise Training, Motor-Motor Dual Task Exercise Training and Cognitive-Motor Dual Task Exercise Training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 39 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Jun 2026to 16 Oct 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Having been diagnosed with Parkinson's disease by a neurologist according to the UK Brain Bank criteria.
- Being in stages 1-3 according to the Hoehn-Yahr Scale.
Who cannot join
- Presence of a neurological disease other than Parkinson's disease
- Cognitive impairment (Standardized Mini Mental Test score less than 24)
- Having undergone deep brain stimulation surgery
- Having a visual, auditory, or perceptual problem
- Having any orthopedic, rheumatological, or other condition that may affect walking and balance.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Gülhane Faculty of Physiotherapy and Rehabilitation
Ankara, Keçiören, 06010
About this study
Official title: Comparison of Motor-Motor and Cognitive-Motor Dual-Task Training in Patients With Parkinson's Disease
The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are:
- Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease in terms of their effects on motor symptoms, balance, gait, functional mobility, activities of daily living, dual-task activities, cognitive functions, and balance confidence.
Read more
Researchers will compare single-task training, motor-motor dual task training and cogvitive-motor dual task training.
Participants will:
- Receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks.
- Participate in assessments at the study clinic before and after exercise training.
- Conditions
- Parkinson's Disease (PD)
- Being tested
- Single Task Exercise Training, Motor-Motor Dual Task Exercise Training, Cognitive-Motor Dual Task Exercise Training
- Keywords
- Parkinson's Disease, Dual Task Training, Motor-Motor, Cognitive-Motor
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Single Task Exercise TrainingOther
Single task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises with a 5-minute rest in between, and then a 5-minute cool-down period.
Motor-Motor Dual Task Exercise TrainingOther
Motor-motor dual task balance and walking exercises. Motor-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with upper extremity motor tasks with a 5-minute rest in between, and then a 5-minute cool-down period.
Cognitive-Motor Dual Task Exercise TrainingOther
Cognitive-motor dual task balance and walking exercises. Cognitive-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with cognitive tasks with a 5-minute rest in between, and then a 5-minute cool-down period.
| Study group | Role | What they receive |
|---|---|---|
| Single Task Training | Active comparator | Single task balance and walking training Receives: Other: Single Task Exercise Training |
| Motor-Motor Dual Task Training | Experimental | Motor-motor dual task balance and walking training Receives: Other: Motor-Motor Dual Task Exercise Training |
| Cognitive-Motor Dual Task Training | Experimental | Cognitive-motor dual task balance and walking training Receives: Other: Cognitive-Motor Dual Task Exercise Training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 3
UPDRS is a reliable and valid scale that assesses cognitive skills, mood, daily living activities, motor skills, motor fluctuations, dyskinesias and autonomic dysfunction and is widely used in clinical studies and research in Parkinson's disease. The motor symptoms section, which is the third section of this scale, will be used.
Measured: From enrollment to the end of training at 6 weeks
Hoehn & Yahr Scale
It is a staging system that provides information quickly in determining the severity and symptoms of Parkinson's disease.
Measured: From enrollment to the end of treatment at 6 weeks
Single-Leg Stance Test
This is a test method used to assess static balance. The patient's preferred foot is raised without touching the supporting leg, and initially, the eyes are open. The eyes are fixed towards the head, and the patient is expected to maintain their balance for 60 seconds. The time the participant maintains their balance is recorded.
Measured: From enrollment to the end of treatment at 6 weeks
Functional Reach Test
This test is designed to assess dynamic balance. In the test, the participant is positioned sideways next to a wall, with their torso upright, the shoulder on the wall flexed to 90°, and the elbow fully extended. The participant is then asked to make a fist with the same arm, and the position of the third metacarpal head is marked on the wall. The participant reaches forward with their knees fully extended; the position of the third metacarpal head is marked again, and the participant returns to the starting position. The difference between the two marks is measured with a tape measure.
Measured: From enrollment to the end of treatment at 6 weeks
10 Meter Walking Test
Participants are asked to walk at normal walking speed for a distance of 10 meters and the time is recorded.
Measured: From enrollment to the end of treatment at 6 weeks
Motor-Motor Dual Task Cost of Walking
To assess the motor-motor dual-task cost of walking, patients will perform the 10-meter walk test once as a single task and once while holding an empty plate on a tray in their hands. The dual-task cost will be calculated as a percentage using the following formula:
[(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]
Measured: From enrollment to the end of treatment at 6 weeks
Cognitive-Motor Dual Task Cost of Walking
To assess cognitive-motor dual-task cost of walking, patients will perform the 10-Meter Walk Test once as a single task and once as a dual-task test, counting backwards in increments of 7 from a three-digit number greater than 300. Dual-task cost will be calculated as a percentage using the following formula:
[(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]
Measured: From enrollment to the end of treatment at 6 weeks
Timed Up and Go Test
This test is used to assess functional mobility levels. The test involves using a standard chair with the individual's knees flexed at 90° and their backrest against it. The individual is asked to stand up from the chair, walk 3 meters, turn around, and then walk back to the chair and sit down. The test begins with the command "walk," and the test duration is measured with a stopwatch and recorded in seconds.
Measured: From enrollment to the end of treatment at 6 weeks
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 2
It consists of thirteen items. The assessment is based on anamnesis information regarding how the patient functions in various activities. The presence of sensory complaints that may be related to tremor and parkinsonism is also included in this section as they can affect daily living activities. Each item is evaluated using a scoring system between '0' and '4'.
Measured: From enrollment to the end of treatment at 6 weeks
Dual Task Questionnaire
This test is used to assess the challenges encountered in daily tasks involving dual work. It consists of 10 questions and is administered via face-to-face interview. Each question is scored between 0 and 4. A score of "4" indicates frequent challenges, while a score of "0" indicates no challenges.
Measured: From enrollment to the end of treatment at 6 weeks
Trail Making Test
It is used to assess executive functions and attention. The test consists of two parts, A and B. In part A, the individual is asked to combine numbers from 1 to 25, and the completion time is recorded. In part B, the individual completes a sequence where each number corresponds to a letter, and the completion time is recorded.
Measured: From enrollment to the end of treatment at 6 weeks
Activity-Specific Balance Confidence Scale
This is a commonly used scale for assessing balance confidence. The scale evaluates whether individuals believe they can perform daily living activities without losing their balance or becoming unsteady. It consists of sixteen items. Each item is scored between a minimum of "0" (unconfident) and a maximum of "100" (completely confident). The base score is calculated by dividing the total score by 16. Higher values indicate that the person feels good about their balance, while lower values are associated with an increased risk of falls.
Measured: From enrollment to the end of treatment at 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jun 2026
- Study start15 Jun 2026
- Primary completion16 Oct 2026
- Study completion16 Oct 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson's Disease (PD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 39 participants (actual)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Collaborators
- Eskisehir Osmangazi University, Anadolu University
- Responsible party
- Principal investigator, Fatih Söke, Saglik Bilimleri Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07641569
- Sponsor's protocol ID
- 2026-152
- Status last verified
- Oct 2026
- First submitted
- 6 Jun 2026
- Last updated
- 21 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Motor-Motor and Cognitive-Motor Dual-Task Training in Patients With Parkinson's Disease
- ClinicalTrials.gov ID
- NCT07641569
- Acronym / sponsor ID
- 2026-152
- Conditions
- Parkinson's Disease (PD)
- Keywords
- Parkinson's Disease, Dual Task Training, Motor-Motor, Cognitive-Motor
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 39 participants (actual)
- Lead sponsor
- Saglik Bilimleri UniversitesiUniversity, hospital or other
- Collaborators
- Eskisehir Osmangazi University, Anadolu University
- Study start
- 15 Jun 2026 (actual)
- Primary completion
- 16 Oct 2026 (actual)
- Study completion
- 16 Oct 2026 (actual)
- First posted
- 11 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are:
- Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease in terms of their effects on motor symptoms, balance, gait, functional mobility, activities of daily living, dual-task activities, cognitive functions, and balance confidence.
Researchers will compare single-task training, motor-motor dual task training and cogvitive-motor dual task training.
Participants will:
- Receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks.
- Participate in assessments at the study clinic before and after exercise training.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Single Task Training | Active comparator | Other: Single Task Exercise TrainingSingle task balance and walking training |
| Motor-Motor Dual Task Training | Experimental | Other: Motor-Motor Dual Task Exercise TrainingMotor-motor dual task balance and walking training |
| Cognitive-Motor Dual Task Training | Experimental | Other: Cognitive-Motor Dual Task Exercise TrainingCognitive-motor dual task balance and walking training |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Having been diagnosed with Parkinson's disease by a neurologist according to the UK Brain Bank criteria.
- Being in stages 1-3 according to the Hoehn-Yahr Scale.
Key exclusion criteria (5 listed)
- Presence of a neurological disease other than Parkinson's disease
- Cognitive impairment (Standardized Mini Mental Test score less than 24)
- Having undergone deep brain stimulation surgery
- Having a visual, auditory, or perceptual problem
- Having any orthopedic, rheumatological, or other condition that may affect walking and balance.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Single Task Exercise TrainingSingle task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises with a 5-minute rest in between, and then a 5-minute cool-down period. | Other | Single Task Training |
| Motor-Motor Dual Task Exercise TrainingMotor-motor dual task balance and walking exercises. Motor-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with upper extremity motor tasks with a 5-minute rest in between, and then a 5-minute cool-down period. | Other | Motor-Motor Dual Task Training |
| Cognitive-Motor Dual Task Exercise TrainingCognitive-motor dual task balance and walking exercises. Cognitive-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with cognitive tasks with a 5-minute rest in between, and then a 5-minute cool-down period. | Other | Cognitive-Motor Dual Task Training |
Primary outcome
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 3
Time frame: From enrollment to the end of training at 6 weeks
UPDRS is a reliable and valid scale that assesses cognitive skills, mood, daily living activities, motor skills, motor fluctuations, dyskinesias and autonomic dysfunction and is widely used in clinical studies and research in Parkinson's disease. The motor symptoms section, which is the third section of this scale, will be used.
Hoehn & Yahr Scale
Time frame: From enrollment to the end of treatment at 6 weeks
It is a staging system that provides information quickly in determining the severity and symptoms of Parkinson's disease.
Single-Leg Stance Test
Time frame: From enrollment to the end of treatment at 6 weeks
This is a test method used to assess static balance. The patient's preferred foot is raised without touching the supporting leg, and initially, the eyes are open. The eyes are fixed towards the head, and the patient is expected to maintain their balance for 60 seconds. The time the participant maintains their balance is recorded.
Functional Reach Test
Time frame: From enrollment to the end of treatment at 6 weeks
This test is designed to assess dynamic balance. In the test, the participant is positioned sideways next to a wall, with their torso upright, the shoulder on the wall flexed to 90°, and the elbow fully extended. The participant is then asked to make a fist with the same arm, and the position of the third metacarpal head is marked on the wall. The participant reaches forward with their knees fully extended; the position of the third metacarpal head is marked again, and the participant returns to the starting position. The difference between the two marks is measured with a tape measure.
10 Meter Walking Test
Time frame: From enrollment to the end of treatment at 6 weeks
Participants are asked to walk at normal walking speed for a distance of 10 meters and the time is recorded.
Motor-Motor Dual Task Cost of Walking
Time frame: From enrollment to the end of treatment at 6 weeks
To assess the motor-motor dual-task cost of walking, patients will perform the 10-meter walk test once as a single task and once while holding an empty plate on a tray in their hands. The dual-task cost will be calculated as a percentage using the following formula: [(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]
Cognitive-Motor Dual Task Cost of Walking
Time frame: From enrollment to the end of treatment at 6 weeks
To assess cognitive-motor dual-task cost of walking, patients will perform the 10-Meter Walk Test once as a single task and once as a dual-task test, counting backwards in increments of 7 from a three-digit number greater than 300. Dual-task cost will be calculated as a percentage using the following formula: [(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]
Timed Up and Go Test
Time frame: From enrollment to the end of treatment at 6 weeks
This test is used to assess functional mobility levels. The test involves using a standard chair with the individual's knees flexed at 90° and their backrest against it. The individual is asked to stand up from the chair, walk 3 meters, turn around, and then walk back to the chair and sit down. The test begins with the command "walk," and the test duration is measured with a stopwatch and recorded in seconds.
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 2
Time frame: From enrollment to the end of treatment at 6 weeks
It consists of thirteen items. The assessment is based on anamnesis information regarding how the patient functions in various activities. The presence of sensory complaints that may be related to tremor and parkinsonism is also included in this section as they can affect daily living activities. Each item is evaluated using a scoring system between '0' and '4'.
Dual Task Questionnaire
Time frame: From enrollment to the end of treatment at 6 weeks
This test is used to assess the challenges encountered in daily tasks involving dual work. It consists of 10 questions and is administered via face-to-face interview. Each question is scored between 0 and 4. A score of "4" indicates frequent challenges, while a score of "0" indicates no challenges.
Trail Making Test
Time frame: From enrollment to the end of treatment at 6 weeks
It is used to assess executive functions and attention. The test consists of two parts, A and B. In part A, the individual is asked to combine numbers from 1 to 25, and the completion time is recorded. In part B, the individual completes a sequence where each number corresponds to a letter, and the completion time is recorded.
Activity-Specific Balance Confidence Scale
Time frame: From enrollment to the end of treatment at 6 weeks
This is a commonly used scale for assessing balance confidence. The scale evaluates whether individuals believe they can perform daily living activities without losing their balance or becoming unsteady. It consists of sixteen items. Each item is scored between a minimum of "0" (unconfident) and a maximum of "100" (completely confident). The base score is calculated by dividing the total score by 16. Higher values indicate that the person feels good about their balance, while lower values are associated with an increased risk of falls.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Oct 2026.
Related trials for Parkinson's Disease (PD)
RecruitingPhase 2
Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
Parkinson's Disease, Deep Brain Stimulation
RecruitingObservational study
Parkinson's Disease in Type 1 Gaucher Disease
Parkinson Disease (PD), Type 1 Gaucher Disease
Recruiting
Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease
REM Sleep Behavior Disorder, Parkinson s Disease
Recruiting
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
PARKINSON DISEASE (Disorder), Parkinson's Disease (PD)
Not yet recruiting
Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD)
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Single Task Exercise Training, Motor-Motor Dual Task Exercise Training and Cognitive-Motor Dual Task Exercise Training in people with Parkinson's Disease (PD), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 3 (time frame: From enrollment to the end of training at 6 weeks). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.